Cargando…
Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
Heart failure following acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Our previous observation that injection of apoptotic peripheral blood mononuclear cell (PBMC) suspensions was able to restore long-term cardiac function in a rat AMI model prompted us to study the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228946/ https://www.ncbi.nlm.nih.gov/pubmed/21952733 http://dx.doi.org/10.1007/s00395-011-0224-6 |
_version_ | 1782217889298776064 |
---|---|
author | Lichtenauer, Michael Mildner, Michael Hoetzenecker, Konrad Zimmermann, Matthias Podesser, Bruno Karl Sipos, Wolfgang Berényi, Ervin Dworschak, Martin Tschachler, Erwin Gyöngyösi, Mariann Ankersmit, Hendrik Jan |
author_facet | Lichtenauer, Michael Mildner, Michael Hoetzenecker, Konrad Zimmermann, Matthias Podesser, Bruno Karl Sipos, Wolfgang Berényi, Ervin Dworschak, Martin Tschachler, Erwin Gyöngyösi, Mariann Ankersmit, Hendrik Jan |
author_sort | Lichtenauer, Michael |
collection | PubMed |
description | Heart failure following acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Our previous observation that injection of apoptotic peripheral blood mononuclear cell (PBMC) suspensions was able to restore long-term cardiac function in a rat AMI model prompted us to study the effect of soluble factors derived from apoptotic PBMC on ventricular remodelling after AMI. Cell culture supernatants derived from irradiated apoptotic peripheral blood mononuclear cells (APOSEC) were collected and injected as a single dose intravenously after myocardial infarction in an experimental AMI rat model and in a porcine closed chest reperfused AMI model. Magnetic resonance imaging (MRI) and echocardiography were used to quantitate cardiac function. Analysis of soluble factors present in APOSEC was performed by enzyme-linked immunosorbent assay (ELISA) and activation of signalling cascades in human cardiomyocytes by APOSEC in vitro was studied by immunoblot analysis. Intravenous administration of a single dose of APOSEC resulted in a reduction of scar tissue formation in both AMI models. In the porcine reperfused AMI model, APOSEC led to higher values of ejection fraction (57.0 vs. 40.5%, p < 0.01), a better cardiac output (4.0 vs. 2.4 l/min, p < 0.001) and a reduced extent of infarction size (12.6 vs. 6.9%, p < 0.02) as determined by MRI. Exposure of primary human cardiac myocytes with APOSEC in vitro triggered the activation of pro-survival signalling-cascades (AKT, Erk1/2, CREB, c-Jun), increased anti-apoptotic gene products (Bcl-2, BAG1) and protected them from starvation-induced cell death. Intravenous infusion of culture supernatant of apoptotic PBMC attenuates myocardial remodelling in experimental AMI models. This effect is probably due to the activation of pro-survival signalling cascades in the affected cardiomyocytes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-011-0224-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3228946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-32289462011-12-27 Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study Lichtenauer, Michael Mildner, Michael Hoetzenecker, Konrad Zimmermann, Matthias Podesser, Bruno Karl Sipos, Wolfgang Berényi, Ervin Dworschak, Martin Tschachler, Erwin Gyöngyösi, Mariann Ankersmit, Hendrik Jan Basic Res Cardiol Original Contribution Heart failure following acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Our previous observation that injection of apoptotic peripheral blood mononuclear cell (PBMC) suspensions was able to restore long-term cardiac function in a rat AMI model prompted us to study the effect of soluble factors derived from apoptotic PBMC on ventricular remodelling after AMI. Cell culture supernatants derived from irradiated apoptotic peripheral blood mononuclear cells (APOSEC) were collected and injected as a single dose intravenously after myocardial infarction in an experimental AMI rat model and in a porcine closed chest reperfused AMI model. Magnetic resonance imaging (MRI) and echocardiography were used to quantitate cardiac function. Analysis of soluble factors present in APOSEC was performed by enzyme-linked immunosorbent assay (ELISA) and activation of signalling cascades in human cardiomyocytes by APOSEC in vitro was studied by immunoblot analysis. Intravenous administration of a single dose of APOSEC resulted in a reduction of scar tissue formation in both AMI models. In the porcine reperfused AMI model, APOSEC led to higher values of ejection fraction (57.0 vs. 40.5%, p < 0.01), a better cardiac output (4.0 vs. 2.4 l/min, p < 0.001) and a reduced extent of infarction size (12.6 vs. 6.9%, p < 0.02) as determined by MRI. Exposure of primary human cardiac myocytes with APOSEC in vitro triggered the activation of pro-survival signalling-cascades (AKT, Erk1/2, CREB, c-Jun), increased anti-apoptotic gene products (Bcl-2, BAG1) and protected them from starvation-induced cell death. Intravenous infusion of culture supernatant of apoptotic PBMC attenuates myocardial remodelling in experimental AMI models. This effect is probably due to the activation of pro-survival signalling cascades in the affected cardiomyocytes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-011-0224-6) contains supplementary material, which is available to authorized users. Springer-Verlag 2011-09-28 2011 /pmc/articles/PMC3228946/ /pubmed/21952733 http://dx.doi.org/10.1007/s00395-011-0224-6 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Contribution Lichtenauer, Michael Mildner, Michael Hoetzenecker, Konrad Zimmermann, Matthias Podesser, Bruno Karl Sipos, Wolfgang Berényi, Ervin Dworschak, Martin Tschachler, Erwin Gyöngyösi, Mariann Ankersmit, Hendrik Jan Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
title | Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
title_full | Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
title_fullStr | Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
title_full_unstemmed | Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
title_short | Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
title_sort | secretome of apoptotic peripheral blood cells (aposec) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228946/ https://www.ncbi.nlm.nih.gov/pubmed/21952733 http://dx.doi.org/10.1007/s00395-011-0224-6 |
work_keys_str_mv | AT lichtenauermichael secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT mildnermichael secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT hoetzeneckerkonrad secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT zimmermannmatthias secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT podesserbrunokarl secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT siposwolfgang secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT berenyiervin secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT dworschakmartin secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT tschachlererwin secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT gyongyosimariann secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy AT ankersmithendrikjan secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy |